Xeroform

DEVICE3 trials

Sponsors

Precisio Biotix Therapeutics, Inc., Joseph M. Still Research Foundation, Inc., Wake Forest University Health Sciences

Conditions

Donor SitesPain ManagementSkin GraftWound DrainageWound HealWound Infection

Phase 1

Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients

Precisio Biotix Therapeutics, Inc.Wound Infection

Start: 2022-01-31End: 2023-08-31Target: 12Updated: 2021-12-22

Phase 3

A Trial Comparing a Cellulose Dressing to Two Standard of Care Dressings in Treating Split Thickness Donor Sites in Burn and Wound Patients.

CompletedNCT05499104

Joseph M. Still Research Foundation, Inc.Donor Sites, Pain Management, Wound Drainage +1

Start: 2021-07-16End: 2022-02-04Updated: 2022-08-12

Phase 4

Pelashield vs Xeroform

Not yet recruitingNCT07734519

Wake Forest University Health SciencesSkin Graft

Start: 2026-10-01End: 2027-07-01Target: 40Updated: 2026-08-25